Breast cancer drug
EPO revokes Novartis everolimus patent in major victory for generics companies
In the long-running dispute with Novartis over breast cancer drug Afinitor, generic drug manufacturers have now scored a major victory. The EPO Boards
...
15 August 2023 by Konstanze Richter